Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 352

1.

The Key Role of Non-governmental Organizations (NGOs) Activities in Viral Hepatitis Elimination Programs.

Padami F, Alavian SM, Niazi M.

Int J Health Policy Manag. 2018 Dec 22;8(3):189-190. doi: 10.15171/ijhpm.2018.125. No abstract available.

2.

Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.

Daneshi-Maskooni M, Keshavarz SA, Qorbani M, Mansouri S, Alavian SM, Badri-Fariman M, Jazayeri-Tehrani SA, Sotoudeh G.

BMC Complement Altern Med. 2019 Mar 12;19(1):59. doi: 10.1186/s12906-019-2465-0.

3.

Mass migration to Europe: an opportunity for elimination of hepatitis B virus?

Thijssen M, Lemey P, Amini-Bavil-Olyaee S, Dellicour S, Alavian SM, Tacke F, Verslype C, Nevens F, Pourkarim MR.

Lancet Gastroenterol Hepatol. 2019 Apr;4(4):315-323. doi: 10.1016/S2468-1253(19)30014-7.

PMID:
30860067
4.

Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting.

Sharafi H, Poustchi H, Azimian F, Tamadoni B, Ramezani R, Gouya MM, Sheikh M, Hashemi F, Tashakorian M, Alasvand R, Alavian SM, Merat S.

J Clin Virol. 2019 Apr;113:20-23. doi: 10.1016/j.jcv.2019.02.005. Epub 2019 Feb 25.

PMID:
30825832
5.

Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level.

Karimzadeh H, Kiraithe MM, Oberhardt V, Salimi Alizei E, Bockmann J, Schulze Zur Wiesch J, Budeus B, Hoffmann D, Wedemeyer H, Cornberg M, Krawczyk A, Rashidi-Alavijeh J, Rodríguez-Frías F, Casillas R, Buti M, Smedile A, Alavian SM, Heinold A, Emmerich F, Panning M, Gostick E, Price DA, Timm J, Hofmann M, Raziorrouh B, Thimme R, Protzer U, Roggendorf M, Neumann-Haefelin C.

Gastroenterology. 2019 May;156(6):1820-1833. doi: 10.1053/j.gastro.2019.02.003. Epub 2019 Feb 12.

6.

Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.

Jazayeri-Tehrani SA, Rezayat SM, Mansouri S, Qorbani M, Alavian SM, Daneshi-Maskooni M, Hosseinzadeh-Attar MJ.

Nutr Metab (Lond). 2019 Jan 28;16:8. doi: 10.1186/s12986-019-0331-1. eCollection 2019.

7.

Lamivudine's efficacy and safety in preventing mother-to-child transmission of hepatitis B: A meta-analysis.

Khalighinejad P, Alavian SM, Fesharaki MG, Jalilianhasanpour R.

Turk J Gastroenterol. 2019 Jan;30(1):66-74. doi: 10.5152/tjg.2018.18148.

8.

Prevalence of hepatitis C virus NS5A resistance-associated substitutions in chronic infection with genotype 1: A pooled analysis based on deposited sequences in GenBank.

Sharafi H, Maleki S, Alavian SM.

Virus Res. 2019 Jan 2;259:54-61. doi: 10.1016/j.virusres.2018.10.014. Epub 2018 Oct 25.

PMID:
30401643
9.

Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?

Sharafi H, Alavian SM.

World J Hepatol. 2018 Sep 27;10(9):543-548. doi: 10.4254/wjh.v10.i9.543.

10.

Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial.

Daneshi-Maskooni M, Keshavarz SA, Qorbani M, Mansouri S, Alavian SM, Badri-Fariman M, Jazayeri-Tehrani SA, Sotoudeh G.

Nutr Metab (Lond). 2018 Sep 25;15:63. doi: 10.1186/s12986-018-0297-4. eCollection 2018.

11.

Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic review.

Haghgoo SM, Sharafi H, Alavian SM.

Clin Chem Lab Med. 2019 Apr 24;57(5):577-610. doi: 10.1515/cclm-2018-0357. Review.

12.

Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C-infected patients with thalassemia.

Khosravi A, Karimi-Sari H, Abedi-Andani M, Behnava B, Namvar A, Anvar A, Alavian SM.

J Med Virol. 2019 Mar;91(3):419-427. doi: 10.1002/jmv.25314. Epub 2018 Oct 9.

PMID:
30204230
13.

Why comprehensive datasets matter when inferring epidemic links or subgenotyping.

Vrancken B, Alavian SM, Aminy A, Amini-Bavil-Olyaee S, Pourkarim MR.

Infect Genet Evol. 2018 Nov;65:350-351. doi: 10.1016/j.meegid.2018.08.012. Epub 2018 Aug 16. No abstract available.

PMID:
30118874
14.

Occult Hepatitis B in Hemodialysis Patients is a Debate.

Alavian SM.

Adv Biomed Res. 2018 Jun 25;7:104. doi: 10.4103/abr.abr_233_16. eCollection 2018. No abstract available.

15.

The role of the Primary Healthcare Network in Iran in hepatitis C virus elimination by 2030.

Behzadifar M, Gorji HA, Rezapour A, Bragazzi NL, Alavian SM.

J Virus Erad. 2018 Jul 1;4(3):186-188.

16.

Hepatitis C screening in patients with oral lichen planus.

Karimi-Sari H, Ghafari Z, Alavian SM.

J Investig Clin Dent. 2018 Aug;9(3):e12350. doi: 10.1111/jicd.12350. Epub 2018 Jul 4. No abstract available.

PMID:
29971956
17.

Hepatitis D virus infection in Kermanshah, west of Iran: seroprevalence and viremic infections.

Sayad B, Naderi Y, Alavian SM, Najafi F, Janbakhsh A, Mansouri F, Vaziri S, Afsharian M, Norooznezhad F.

Gastroenterol Hepatol Bed Bench. 2018 Spring;11(2):145-152.

18.

Comment on 'Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study'.

Alavian SM, Sharafi H.

Eur J Gastroenterol Hepatol. 2018 Jul;30(7):807-808. doi: 10.1097/MEG.0000000000001124. No abstract available.

PMID:
29847527
19.

Immigration and knowledge, education, and practices regarding chronic hepatitis B in pregnancy.

Alavian SM.

Ann Gastroenterol. 2018 May-Jun;31(3):384. doi: 10.20524/aog.2018.0246. Epub 2018 Mar 15. No abstract available.

20.

Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8+ T Cells.

Karimzadeh H, Kiraithe MM, Kosinska AD, Glaser M, Fiedler M, Oberhardt V, Salimi Alizei E, Hofmann M, Mok JY, Nguyen M, van Esch WJE, Budeus B, Grabowski J, Homs M, Olivero A, Keyvani H, Rodríguez-Frías F, Tabernero D, Buti M, Heinold A, Alavian SM, Bauer T, Schulze Zur Wiesch J, Raziorrouh B, Hoffmann D, Smedile A, Rizzetto M, Wedemeyer H, Timm J, Antes I, Neumann-Haefelin C, Protzer U, Roggendorf M.

J Virol. 2018 Jun 13;92(13). pii: e01891-17. doi: 10.1128/JVI.01891-17. Print 2018 Jul 1.

21.

A facile PCR-RFLP method for genotyping of ITPA rs1127354 and rs7270101 polymorphisms.

Alavian SE, Sharafi H, Shirmast P, Alavian SM, Behnava B, Pouryasin M, Keshvari M, Pouryasin A.

J Clin Lab Anal. 2018 Sep;32(7):e22440. doi: 10.1002/jcla.22440. Epub 2018 Apr 16.

PMID:
29660762
22.

Detection of Hepatitis C Virus RNA in Blood and Saliva of Transfusion-Dependent Thalassemia Patients Diagnosed with Hepatitis C.

Hooshmand B, Alavian SM, Kouhestani F, Firouzmandi M, Motamedian SR.

Contemp Clin Dent. 2018 Jan-Mar;9(1):5-9. doi: 10.4103/ccd.ccd_297_17.

23.

Art and viral hepatitis elimination programmes.

Nima M, Karimi-Sari H, Alavian SM.

J Virus Erad. 2018 Jan 1;4(1):59-60.

24.

Molecular evolution and phylodynamics of hepatitis B virus infection circulating in Iran.

Mozhgani SH, Malekpour SA, Norouzi M, Ramezani F, Rezaee SA, Poortahmasebi V, Sadeghi M, Alavian SM, Zarei-Ghobadi M, Ghaziasadi A, Karimzadeh H, Malekzadeh R, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Jahantigh HR, Somi MH, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Keyvani H, Kalantari E, Fakhari Z, Geravand B, Jazayeri SM.

Arch Virol. 2018 Jun;163(6):1479-1488. doi: 10.1007/s00705-018-3764-3. Epub 2018 Feb 13.

PMID:
29442226
25.

Anesthetic Considerations in Patients Undergoing Bariatric Surgery: A Review Article.

Soleimanpour H, Safari S, Sanaie S, Nazari M, Alavian SM.

Anesth Pain Med. 2017 Jul 11;7(4):e57568. doi: 10.5812/aapm.57568. eCollection 2017 Aug. Review.

26.

Letter to the Editor: The Clear and Present Danger to Portuguese Travelers to the Middle East Region.

Alavian SM.

Acta Med Port. 2017 Dec 29;30(12):892. doi: 10.20344/amp.9794. Epub 2017 Dec 29. No abstract available.

27.

Viral hepatitis elimination should receive more attention from Iranian nurses.

Bayatpoor ME, Karimi-Sari H, Alavian SM.

Res Nurs Health. 2018 Feb;41(1):9-10. doi: 10.1002/nur.21847. Epub 2017 Dec 20. No abstract available.

PMID:
29266371
28.
29.

The impact of KIR-HLA genotype on hepatitis B virus clearance in Iranian infected individuals.

Shah-Hosseini A, Jafari M, Mohammadi A, Sanaei R, Alavian SM, Doosti-Irani A, Nooradeh Keykavousi M, Tajik N.

Med Microbiol Immunol. 2017 Dec;206(6):463-470. doi: 10.1007/s00430-017-0522-1. Epub 2017 Oct 14.

PMID:
29032460
30.

Knowledge, attitude, and practice of Iranian health sciences students regarding hepatitis B and C virus infections: A national survey.

Karimi-Sari H, Bayatpoor ME, Aftabi Khotbesara M, Ebrahimi MS, Sattari Z, Sattari P, Saberi Shakib N, Taheri H, Abdolrahim Poor Heravi S, Dinizadeh M, Vahed P, Shirsavar K, Hosseini H, Rashvand S, Jalaei D, Azarafraz M, Naderi M, Pourzakaria M, Firoozbakht M, Khosravi MH, Alavian SM.

Am J Infect Control. 2017 Nov 1;45(11):e135-e141. doi: 10.1016/j.ajic.2017.07.012. Epub 2017 Oct 12.

PMID:
28893448
31.

Incidence and Residual Risk of HIV, HBV and HCV Infections Among Blood Donors in Tehran.

Saber HR, Tabatabaee SM, Abasian A, Jamali M, SalekMoghadam E, Hajibeigi B, Alavian SM, Mirrezaie SM.

Indian J Hematol Blood Transfus. 2017 Sep;33(3):412-416. doi: 10.1007/s12288-016-0732-5. Epub 2016 Oct 1.

32.

Effects of a Low-Calorie, Low-Carbohydrate Soy Containing Diet on Systemic Inflammation Among Patients with Nonalcoholic Fatty Liver Disease: A Parallel Randomized Clinical Trial.

Kani AH, Alavian SM, Esmaillzadeh A, Adibi P, Haghighatdoost F, Azadbakht L.

Horm Metab Res. 2017 Sep;49(9):687-692. doi: 10.1055/s-0042-118707. Epub 2017 Jul 31.

PMID:
28759939
33.

DNA microarray technology in HBV genotyping.

Behzadi P, Behzadi E, Alavian SM.

Minerva Med. 2017 Oct;108(5):473-476. doi: 10.23736/S0026-4806.17.05059-5. No abstract available.

PMID:
28728341
34.

Innate immunity related pathogen recognition receptors and chronic hepatitis B infection.

Nosratabadi R, Alavian SM, Zare-Bidaki M, Shahrokhi VM, Arababadi MK.

Mol Immunol. 2017 Oct;90:64-73. doi: 10.1016/j.molimm.2017.07.002. Epub 2017 Jul 10. Review.

PMID:
28704708
35.

Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol.

Jazayeri-Tehrani SA, Rezayat SM, Mansouri S, Qorbani M, Alavian SM, Daneshi-Maskooni M, Hosseinzadeh-Attar MJ.

BMJ Open. 2017 Jul 10;7(7):e016914. doi: 10.1136/bmjopen-2017-016914.

36.

Hepatitis E virus seroprevalence rate among Eastern Mediterranean and middle eastern countries; A systematic review and pooled analysis.

Karbalaie Niya MH, Rezaee-Zavareh MS, Ranaei A, Alavian SM.

Microb Pathog. 2017 Sep;110:252-256. doi: 10.1016/j.micpath.2017.06.045. Epub 2017 Jul 5. Review.

PMID:
28688980
37.

The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.

Daneshi-Maskooni M, Keshavarz SA, Mansouri S, Qorbani M, Alavian SM, Badri-Fariman M, Jazayeri-Tehrani SA, Sotoudeh G.

Trials. 2017 Jun 7;18(1):260. doi: 10.1186/s13063-017-1979-3.

38.

Inactive Hepatitis B Carrier and Pregnancy Outcomes: A Systematic Review and Meta-analysis.

Keramat A, Younesian M, Gholami Fesharaki M, Hasani M, Mirzaei S, Ebrahimi E, Alavian SM, Mohammadi F.

Iran J Public Health. 2017 Apr;46(4):468-474. Review.

39.

Toll like receptor 4 and hepatocellular carcinoma; A systematic review.

Sepehri Z, Kiani Z, Kohan F, Alavian SM, Ghavami S.

Life Sci. 2017 Jun 15;179:80-87. doi: 10.1016/j.lfs.2017.04.025. Epub 2017 May 1. Review.

PMID:
28472619
40.

Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis.

Dolatimehr F, Karimi-Sari H, Rezaee-Zavareh MS, Alavian SM, Behnava B, Gholami-Fesharaki M, Sharafi H.

Daru. 2017 Apr 20;25(1):11. doi: 10.1186/s40199-017-0177-x. Review.

41.

Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis.

Rezaee-Zavareh MS, Hesamizadeh K, Behnava B, Alavian SM, Gholami-Fesharaki M, Sharafi H.

Ann Hepatol. 2017 March-April;16(2):188-197. doi: 10.5604/16652681.1231562. Review. No abstract available.

42.

A Cost-Utility Analysis of Different Antiviral Medicine Regimens in Patients With Chronic Hepatitis C Virus Genotype 1 Infection.

Alavian SM, Nikfar S, Kebriaeezadeh A, Lotfi F, Sanati E, Rezaei Hemami M, Keshavarz K.

Iran Red Crescent Med J. 2016 Oct 2;18(11):e37094. doi: 10.5812/ircmj.37094. eCollection 2016 Nov.

43.

Iran's research needs to be more noticed - Authors' reply.

Rezaee-Zavareh MS, Salamati P, Alavian SM.

Lancet. 2017 Feb 4;389(10068):504. doi: 10.1016/S0140-6736(17)30235-0. No abstract available.

PMID:
28170334
44.

Increasing the Awareness of the General Population: An Important Step in Elimination Programs of Viral Hepatitis.

Karimi-Sari H, Tajik M, Bayatpoor ME, Alavian SM.

Am J Gastroenterol. 2017 Feb;112(2):393-395. doi: 10.1038/ajg.2016.534. No abstract available.

PMID:
28154404
45.

Necessity for Hepatitis B Surface Antigen Screening in Pregnant Females in Iran.

Alavian SM, Ebrahimi E, Abedini M.

Iran Red Crescent Med J. 2016 Jul 25;18(9):e40844. doi: 10.5812/ircmj.40844. eCollection 2016 Sep. No abstract available.

46.

Molecular Tracing of Hepatitis C Virus Genotype 1 Isolates in Iran: A NS5B Phylogenetic Analysis with Systematic Review.

Hesamizadeh K, Alavian SM, Najafi Tireh Shabankareh A, Sharafi H.

Hepat Mon. 2016 Nov 19;16(12):e42938. doi: 10.5812/hepatmon.42938. eCollection 2016 Dec. Review.

47.

Liver Mitochondrial DNA Copy Number and Deletion Levels May Contribute to Nonalcoholic Fatty Liver Disease Susceptibility.

Kamfar S, Alavian SM, Houshmand M, Yadegarazari R, Seifi Zarei B, Khalaj A, Shabab N, Saidijam M.

Hepat Mon. 2016 Nov 9;16(12):e40774. doi: 10.5812/hepatmon.40774. eCollection 2016 Dec.

48.

Sero-Prevalence of Bloodborne Tumor Viruses (HCV, HBV, HTLV-I and KSHV Infections) and Related Risk Factors among Prisoners in Razavi Khorasan Province, Iran, in 2008.

Khajedaluee M, Babaei A, Vakili R, Valizade N, Homaei Shandiz F, Alavian SM, Seyed Nozadi M, Jazayeri SM, Hassannia T.

Hepat Mon. 2016 Dec 3;16(12):e31541. doi: 10.5812/hepatmon.31541. eCollection 2016 Dec.

49.

Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis.

Ashkani-Esfahani S, Alavian SM, Salehi-Marzijarani M.

World J Gastroenterol. 2017 Jan 7;23(1):151-166. doi: 10.3748/wjg.v23.i1.151. Review.

50.

Street and labour children; special group for elimination of viral hepatitis in Iran.

Karimi-Sari H, Rezaee-Zavareh MS, Alavian SM.

Sex Transm Infect. 2017 Feb;93(1):38. doi: 10.1136/sextrans-2016-052890. No abstract available.

PMID:
28100760

Supplemental Content

Loading ...
Support Center